Showing 81 - 100 results of 227 for search '"head and neck cancer"', query time: 0.06s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85

    A time frame evaluation of the oral health-related quality of life among patients with head and neck cancer by Raquel D'Aquino Garcia Caminha, Rogério Jardim Caldas, Isabela Camera Messias Bueno, Ana Cláudia Scaraficci, Paulo Sergio da Silva Santos

    Published 2024-09-01
    “…Background: We evaluated the oral health-related quality of life among patients with head and neck cancer. Material and methods: The Oral Impact Profile (OHIP-14) questionnaire was applied at four distinct moments of antineoplastic therapy. …”
    Get full text
    Article
  6. 86
  7. 87
  8. 88
  9. 89

    Genetic Polymorphisms in the RAD51 Gene with a Risk of Head and Neck Cancer and Esophageal Cancer: A Meta-Analysis by Lin Li, Xue Zhang, Zhong-Ti Zhang

    Published 2019-01-01
    “…The role of RAD51 gene polymorphisms with the development of head and neck cancer (HNC) and esophageal cancer (EC) remains controversial. …”
    Get full text
    Article
  10. 90
  11. 91
  12. 92

    Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints by Fatemeh Nosrat, Cem Dede, Lucas B. McCullum, Raul Garcia, Abdallah S.R. Mohamed, Jacob G. Scott, James E. Bates, Brigid A. McDonald, Kareem A. Wahid, Mohamed A. Naser, Renjie He, Aysenur Karagoz, Amy C. Moreno, Lisanne V. van Dijk, Kristy K. Brock, Jolien Heukelom, Seyedmohammadhossein Hosseinian, Mehdi Hemmati, Andrew J. Schaefer, Clifton D. Fuller

    Published 2025-01-01
    “…The purpose of this study was to determine the personalized optimal timing of re-planning in adaptive OAR-sparing radiation therapy, considering limited re-planning resources, for patients with head and neck cancer (HNC). Materials and methods: A novel Markov decision process (MDP) model was developed to determine optimal timing of re-planning based on the patient’s expected toxicity, characterized by normal tissue complication probability (NTCP), for four toxicities. …”
    Get full text
    Article
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97
  18. 98
  19. 99

    Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials by Cristina Gurizzan, Michela Cinquini, Lorenzo Legramandi, Carlo Resteghini, Marco Siano, Cristiana Bergamini, Luigi Lorini, Davide Smussi, Alberto Paderno, Lisa Licitra, Paolo Bossi

    Published 2025-01-01
    “…Objectives: A combination of chemotherapy and radiotherapy is employed in the curative and postoperative treatment of locally advanced head and neck cancers (HNC). Integrated chemoradiation (CRT) treatments result in a non-negligible rate of severe toxic effects. …”
    Get full text
    Article
  20. 100